E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/17/2016 in the Prospect News Structured Products Daily.

New Issue: RBC prices $3.85 million trigger phoenix autocallables linked to funds

By Susanna Moon

Chicago, June 17 – Royal Bank of Canada priced $3.85 million of trigger phoenix autocallable notes due June 14, 2018 linked to the worst performing of the iShares Nasdaq Biotechnology exchange traded fund, Financial Select Sector SPDR fund and Technology Select Sector SPDR fund, according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a contingent quarterly coupon of 9.95% per year if each underlying fund closes at or above its coupon barrier level, 65% of its initial price, on the observation date for that quarter.

The notes will be called at par if each fund closes at or above its initial price on any quarterly observation date.

The payout at maturity will be par plus the final contingent coupon unless any fund finishes below its 65% trigger level, in which case investors will be fully exposed to any losses of the worst performing fund.

RBC Capital Markets, LLC is the agent.

Issuer:Royal Bank of Canada
Issue:Trigger phoenix autocallable notes
Underlying funds:iShares Nasdaq Biotechnology ETF, Financial Select Sector SPDR fund and Technology Select Sector SPDR fund
Amount:$3,853,000
Maturity:June 14, 2018
Coupon:9.95% annualized, payable quarterly if each fund closes at or above 65% coupon barrier on observation date for that quarter
Price:Par
Payout at maturity:Par unless any fund finishes below trigger level, in which case full exposure to any losses of worst performing fund
Call:At par if each fund closes at or above initial price on any quarterly observation date
Initial levels:$267.60 for Nasdaq biotech fund, $23.18 for financial fund and $43.96 for tech fund
Trigger levels:$173.94 for Nasdaq biotech fund, $15.07 for financial fund and $28.57 for tech fund; 65% of initial levels
Pricing date:June 10
Settlement date:June 14
Agent:RBC Capital Markets LLC
Fees:1.75%
Cusip:78012KQE0

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.